Introduction: Global Value of Innovative Intermediates
In the fields of pharmaceutical and agrochemical research, 5-Bromo-1-pentene (CAS 1119-51-3) has become a pivotal raw material for constructing complex active molecules. Its unique bromo-alkene structure endows it with remarkable reaction versatility, while Shanghai Xinchem’s large-scale production capabilities and compliance advantages position us as a strategic partner for European and American enterprises seeking to optimize their supply chains. This article will comprehensively analyze the value of this intermediate from four dimensions: product characteristics, core applications, market trends, and corporate advantages.
I. Product Characteristics: Dual Assurance of High Purity and Compliance
1.1 Molecular Structure and Physicochemical Properties
The molecular formula of 5-Bromo-1-pentene is C5H9Br, with a molecular weight of 149.03 g/mol. The synergistic effect between its bromine atom and alkene double bond enables excellent performance in organic synthesis reactions such as Friedel-Crafts and Grignard reactions. With a boiling point of 126–127°C and a flash point of 30°C, it ensures safer transportation in low-temperature or inert environments, effectively reducing storage risks.
1.2 Purity and Compliance Advantages
Shanghai Xinchem’s 5-Bromo-1-pentene boasts a purity of ≥98.5% and impurity content of <0.5%, fully complying with pharmaceutical-grade intermediate specifications such as EU REACH, US FDA, and ICH Q3D. Certified by ISO 9001 quality management system, every batch undergoes rigorous quality inspection to meet the stringent purity requirements of European and American clients.
II. Core Applications: Cornerstone of Pharma and Agrochemical R&D
2.1 Pharma Sector: Key Intermediate for Anticancer and Hormone Drugs
Anticancer Drug Synthesis: As a starting material for neurotoxins like DL-Xiwatoxin, it accelerates anticancer drug development through Friedel-Crafts reactions to build complex molecular frameworks. For example, a European pharmaceutical company reduced its new drug application cycle by 30% after adopting this intermediate.
Hormone Drug Development: Serving as a synthetic precursor for hormones like 7α-(3-carboxypropyl)estradiol, its bromo-alkene structure enables multi-step reactions to enhance product yield and stability.
2.2 Agrochemical Sector: Innovative Material for New Fungicides and Insecticides
Sulfonamide Fungicides: Derivatives exhibit significant antifungal activity against pathogens like Botrytis cinerea. A German agrochemical company developed a fungicide with 40% enhanced efficacy using this intermediate, gaining EU market approval.
Benzophenone Fatty Acid Insecticides: Generated via Grignard reactions with methyl benzoate, these derivatives offer targeted mechanisms for green pesticide development.
2.3 Materials Science: Building Block for Functional Polymers
In flame retardants and specialty coatings, it participates in synthesizing high-molecular-weight materials containing hexacyclic nitrogen heterocycles, improving thermal stability and flame retardancy.
III. European and American Market Analysis: Growth Opportunities Driven by Compliance
3.1 Pharma Sector: 5-Bromo-1-pentene (CAS 1119-51-3) R&D Boom for Anticancer and Antibiotic Drugs
Anticancer Drug Demand: Rising global cancer incidence fuels demand for intermediates like those in DL-Xiwatoxin. A US biotech company reduced intermediate costs by 25% through optimized synthesis.
Antibiotic Innovation: With growing antibiotic resistance, derivatives with <0.5% impurities enhance product stability in new antibiotic development.
3.2 Agrochemical Sector: Transition to Green and Efficient Products
Fungicide Market: Increased resistance to traditional fungicides drives demand for new sulfonamide-based products. This intermediate’s 40% efficacy boost makes it a preferred choice.
Insecticide Innovation: Benzophenone fatty acid-based insecticides reduce non-target impact, aligning with EU environmental regulations.
3.3 Compliance Requirements: Market Entry Thresholds
EU REACH Regulation: Mandating registration, evaluation, authorization, and restriction of chemicals, its compliance documents (COA, MSDS) facilitate swift approval.
US FDA Guidelines: Strict purity and impurity control for pharmaceutical intermediates are met through third-party certifications, alleviating compliance concerns.
IV. Advantages of Choosing Shanghai Xinchem: Triple Safeguard of Scale, Cost, and Service
4.1 Large-Scale Production: Stable Supply and Cost Optimization
Annual Capacity of 500 tons: Through centralized raw material procurement and process optimization, unit costs are reduced by 15%-20%, with a 99.5% on-time delivery rate (2024 data), preventing production disruptions.
Flexible Packaging Options: Custom-sized containers (25/50/200 kg) minimize inventory waste and enhance supply chain efficiency.
4.2 Cost-Effectiveness: Hidden Cost Savings and R&D Efficiency
Compliance Risk Mitigation: Aligning with EU and US environmental regulations helps avoid fines or project termination risks. A European pharmaceutical company reported a 20% reduction in R&D delay costs.
R&D Efficiency Boost: High-purity intermediates reduce purification steps, accelerating drug screening. A US company achieved a 25% shorter synthesis cycle.
4.3 Service Support: Localization and Comprehensive Compliance
European Local Warehousing: Shortens delivery cycles and improves logistics efficiency.
Full Compliance Documentation: Provides COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and REACH/FDA declarations, ensuring peace of mind.
Technical Support Team: 24/7 responsiveness for customized synthesis solutions and process optimization advice.
V. Customer Cases: Real-World Value Validation
5.1 Pharma Sector: Successful Practices in Anticancer Drug Synthesis
European Pharmaceutical Company: Reduced total synthesis costs by 25% and cut new drug application cycles by 30%.
US Biotech Company: Achieved strict impurity control (<0.5%) and significantly improved product stability.
5.2 Agrochemical Sector: Breakthroughs in Fungicide and Insecticide Innovation
German Agrochemical Enterprise: Developed a fungicide with 40% enhanced efficacy against Botrytis cinerea, gaining EU market access.
French Pesticide R&D Institute: Created targeted insecticides with reduced non-target impact, meeting EU green standards.
Meet XINCHEM, Co-Create a New Chapter in Production and R&D
5-Bromo-1-pentene (CAS 1119-51-3), with its exceptional purity, comprehensive compliance, and significant cost advantages, has become an indispensable strategic raw material for pharmaceutical and agrochemical R&D in Europe and North America. Shanghai XINCHEM Chemical, leveraging its large-scale production capabilities, complete compliance support, and flexible supply chain systems, is committed to helping customers reduce overall manufacturing costs and accelerate R&D progress.
Contact XinChem now to get customized solutions!
Official Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: Nov-26-2025